These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39134329)

  • 1. Continuous sampling of healthy and mastitic quarters of lactating cattle by ultrafiltration after intramammary ceftiofur hydrochloride administration.
    Mzyk DA; Halleran JL; Sylvester HJ; Giles CB; Jacob ME; Baynes RE; Foster DM
    J Vet Intern Med; 2024; 38(5):2814-2822. PubMed ID: 39134329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination kinetics of ceftiofur hydrochloride after intramammary administration in lactating dairy cows.
    Smith GW; Gehring R; Riviere JE; Yeatts JL; Baynes RE
    J Am Vet Med Assoc; 2004 Jun; 224(11):1827-30. PubMed ID: 15198270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short communication: Use of an ultrafiltration device in gland cistern for continuous sampling of healthy and mastitic quarters of lactating cattle for pharmacokinetic modeling.
    Mzyk DA; Bublitz CM; Sylvester H; Mullen KAE; Hobgood GD; Baynes RE; Foster DM
    J Dairy Sci; 2018 Nov; 101(11):10414-10420. PubMed ID: 30197136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis.
    Fuenzalida MJ; Ruegg PL
    J Dairy Sci; 2019 Jun; 102(6):5438-5457. PubMed ID: 30981475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.
    Oliver SP; Gillespie BE; Headrick SJ; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC; Chester ST; Moseley WM
    J Dairy Sci; 2004 Aug; 87(8):2393-400. PubMed ID: 15328260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramammary treatment of clinical mastitis quarters with ceftiofur does not cause anbiotic residues in adjacent untreated quarters.
    Carvalho ALMA; Nascimento Neto JDP; Carvalho TBT; Lima Neto HR; Victali RM; Chalfun LHL
    J Dairy Res; 2024 Feb; 91(1):73-75. PubMed ID: 38361414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle.
    Oliver SP; Almeida RA; Gillespie BE; Headrick SJ; Dowlen HH; Johnson DL; Lamar KC; Chester ST; Moseley WM
    J Dairy Sci; 2004 Oct; 87(10):3322-9. PubMed ID: 15377611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negatively controlled, randomized clinical trial to evaluate use of intramammary ceftiofur for treatment of nonsevere culture-negative clinical mastitis.
    Fuenzalida MJ; Ruegg PL
    J Dairy Sci; 2019 Apr; 102(4):3321-3338. PubMed ID: 30738678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination kinetics of ceftiofur hydrochloride in milk after an 8-day extended intramammary administration in healthy and infected cows.
    Han R; Li S; Wang J; Yu Z; Wang J; Zheng N
    PLoS One; 2017; 12(11):e0187261. PubMed ID: 29095869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short communication: Pharmacokinetics of intramammary hetacillin in dairy cattle milked 3 times per day.
    Lindquist DA; Baynes RE; Smith GW
    J Dairy Sci; 2015 Mar; 98(3):1856-61. PubMed ID: 25547305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intramammary infusion of ceftiofur hydrochloride at drying off for treatment and prevention of bovine mastitis during the nonlactating period.
    Hallberg JW; Wachowski M; Moseley WM; Dame KJ; Meyer J; Wood SL
    Vet Ther; 2006; 7(1):35-42. PubMed ID: 16598682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal milk microbiome is reestablished following experimental infection with Escherichia coli independent of intramammary antibiotic treatment with a third-generation cephalosporin in bovines.
    Ganda EK; Gaeta N; Sipka A; Pomeroy B; Oikonomou G; Schukken YH; Bicalho RC
    Microbiome; 2017 Jul; 5(1):74. PubMed ID: 28701174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy.
    Owens WE; Xiang ZY; Ray CH; Nickerson SC
    J Dairy Sci; 1990 Dec; 73(12):3449-56. PubMed ID: 2099366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short communication: Longitudinal study of quarter-level somatic cell responses after naturally occurring, nonsevere clinical mastitis diagnosed as culture negative, or caused by Escherichia coli or Klebsiella pneumoniae, and randomly assigned to a no-treatment group or to receive intramammary ceftiofur.
    Fuenzalida MJ; Ruegg PL
    J Dairy Sci; 2019 Dec; 102(12):11476-11482. PubMed ID: 31629523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negatively controlled, randomized clinical trial comparing different antimicrobial interventions for treatment of clinical mastitis caused by gram-positive pathogens.
    Tomazi T; Sumnicht M; Tomazi ACCH; Silva JCC; Bringhenti L; Duarte LM; Silva MMM; Rodrigues MX; Bicalho RC
    J Dairy Sci; 2021 Mar; 104(3):3364-3385. PubMed ID: 33358798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial.
    Truchetti G; Bouchard E; Descôteaux L; Scholl D; Roy JP
    Can J Vet Res; 2014 Jan; 78(1):31-7. PubMed ID: 24396178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered plasma pharmacokinetics of ceftiofur hydrochloride in cows affected with severe clinical mastitis.
    Gorden PJ; Kleinhenz MD; Wulf LW; KuKanich B; Lee CJ; Wang C; Coetzee JF
    J Dairy Sci; 2016 Jan; 99(1):505-14. PubMed ID: 26601579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
    Schukken YH; Bennett GJ; Zurakowski MJ; Sharkey HL; Rauch BJ; Thomas MJ; Ceglowski B; Saltman RL; Belomestnykh N; Zadoks RN
    J Dairy Sci; 2011 Dec; 94(12):6203-15. PubMed ID: 22118109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: use of the BetaStar Plus assay for detection of ceftiofur antimicrobial residues in milk from individual cows following intramammary treatment for mastitis.
    Grooms DL; Norby B; Grooms KE; Jagodzinski EN; Erskine RJ; Halbert LW; Coetzee JF; Wulf L; Rice JA
    J Dairy Sci; 2015 Sep; 98(9):6270-7. PubMed ID: 26188576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Events occurring during the previous lactation, the dry period, and peripartum as risk factors for early lactation mastitis in cows receiving 2 different intramammary dry cow therapies.
    Pinedo PJ; Fleming C; Risco CA
    J Dairy Sci; 2012 Dec; 95(12):7015-26. PubMed ID: 22999278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.